Privigen 10% vial 50ML
Ended Awarded
- Contract number
- SPE2DB25FAZKW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,364
Award facts
- Contract value 100% obligated
- $4,363.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on September 22, 2025, by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., covers the supply of PRIVIGEN 10% Vial 50ML, a human immune globulin intravenous (IGIV) treatment used for immunodeficiency conditions and various immune-related disorders. The firm fixed-price delivery order carries a ceiling value of $4,363.50 with an ultimate completion date of October 14, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, fulfills this order through its position as a key supplier under the Defense Logistics Agency's larger Indefinite Delivery Contract valued at $499.999 billion and extending through November 2026. No set-aside designation was applied to this award.
DMS Pharmaceutical Group leverages its woman-owned small business status and established relationship with the Defense Logistics Agency to supply critical pharmaceutical products to military healthcare facilities nationwide. The company's robust federal contracting portfolio includes specialized medications spanning oncology treatments, vaccines, biologics, and various medical consumables. This delivery order exemplifies the Defense Logistics Agency's procurement strategy of utilizing indefinite delivery contracts to efficiently source pharmaceutical supplies required across Department of Defense medical facilities, ensuring reliable access to essential medications and immune globulin products for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FAZKW?
SPE2DB25FAZKW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FAZKW worth?
The government has obligated $4,364 on SPE2DB25FAZKW.
Is contract SPE2DB25FAZKW an order under another contract?
Yes. SPE2DB25FAZKW is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZKW competed?
The extent of competition for SPE2DB25FAZKW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award